[Image source=EPA Yonhap News]

[Image source=EPA Yonhap News]

View original image


[Asia Economy Beijing=Special Correspondent Park Sun-mi] Zhong Nanshan, the top authority on infectious diseases in China and an academician of the Chinese Academy of Engineering, announced that COVID-19 vaccines could be available for human administration around September.


According to China Central Television (CCTV) on the 19th, Zhong stated at a COVID-19 prevention press conference held in Guangzhou the previous day that China is currently conducting research on five types of COVID-19 vaccines: whole-virus vaccines, nucleic acid vaccines, adenovirus vaccines, gene protein vaccines, and influenza-type vaccines. He said that human administration could be possible around September.


He explained, "China's vaccine development is progressing at a very fast pace. There is no difference compared to the United States. The U.S. has said that COVID-19 vaccines could be administered to humans around September, and China is expected to be able to do so at a similar time."



He added, "Vaccines are the most fundamental solution to COVID-19. Regardless of which country releases the vaccine, it cannot supply the entire world alone. We need to learn from each other and complement shortcomings so that production can occur in many places, enabling sufficient global supply."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing